Literature DB >> 6149718

Sulfasalazine and ankylosing spondylitis.

B Amor, A Kahan, M Dougados, F Delrieu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6149718     DOI： 10.7326/0003-4819-101-6-878_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Recent developments in the therapy of spondyloarthropathies.

Authors:  M Stone; R D Inman
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

2.  Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis.

Authors:  G J Carroll; R K Will; P D Breidahl; L M Tinsley
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer.

Authors:  Lv Yang; Tang WenTao; Zhang ZhiYuan; Lin Qi; Luo YuXiang; Zheng Peng; Li Ke; Jia XiaoNa; Pang YuZhi; Ji MeiLing; Feng QingYang; He GuoDong; Wang YueXiang; Xu JianMin
Journal:  Oncogene       Date:  2022-05-03       Impact factor: 9.867

Review 4.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

5.  Evaluation of sulphasalazine in the treatment of spondyloarthropathies.

Authors:  M Dougados; A Maetzel; M Mijiyawa; B Amor
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

6.  Ankylosing spondylitis. Current drug treatment.

Authors:  J T Gran; G Husby
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

7.  Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.

Authors:  M Dougados; P Boumier; B Amor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

8.  Salmonella reactive arthritis in established ankylosing spondylitis.

Authors:  I R Paul; E S Mitchell; A L Bell
Journal:  Ulster Med J       Date:  1988-10

9.  Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.

Authors:  Qiuxia Li; Li Li; Liqi Bi; Changhong Xiao; Zhiming Lin; Shuangyan Cao; Zetao Liao; Jieruo Gu
Journal:  Trials       Date:  2016-07-22       Impact factor: 2.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.